YSOPIA Bioscience, a leading biotech in next-generation microbiome-based biotherapies that harness the power of keystone single-strain bacteria
Our team is committed to deliver groundbreaking therapeutic solutions to patients with high needs
YSOPIA Bioscience is the 1st company to harness the therapeutic potential of Christensenella
Our leadership
Putting people first
Fabrice is an accomplished executive with more than two decades of experience within biotech environment and pharmaceutical SMEs. He co-founded YSOPIA Bioscience.
Beyond the state of the art
Sandrine joined YSOPIA Bioscience in 2017 as Chief Scientific Officer. She previously served as Associate Professor in Integrative Metabolism at the University of Reading’s department of Food and Nutritional Sciences.
Execute the right project
Frederic’s expertise focuses on project management and innovation in the different positions he held in the hospital & health care industry.
A growth mindset
Marion joined YSOPIA Bioscience in 2017. She currently leads the business development and pipeline strategy of the Company, as well as the IP strategy.
to meet us
